Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of β-catenin mutation

Cancer Letters

Volumn 183, Issue 1, 2002, Pages 31-41

  Suzui, Masumi ^a,d   Okuno, Masataka ^a   Tanaka, Takuji ^b   Nakagama, Hitoshi ^c   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d Columbia University ^*  (United States)

Author keywords

Catenin mutation; C57BL 6J mice; Colon carcinogenesis; Multiple intestinal neoplasia mice

Indexed keywords

AZOXYMETHANE; BETA CATENIN;

ADENOMATOUS POLYP; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; GENE MUTATION; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; WILD TYPE;

ADENOCARCINOMA; ADENOMA; ANIMALS; AZOXYMETHANE; BETA CATENIN; CARCINOGENS; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; DNA PRIMERS; MALE; MICE; MICE, INBRED C57BL; MUTAGENESIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANS-ACTIVATORS;

ANIMALIA;

EID: 0037044114     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00114-3     Document Type: Article

References (38)

1. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC -/- colon carcinoma
2. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
3. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
4. Identification of c-MYC as a target of the APC pathway
5. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors
6. High frequency of β-catenin (Ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat
7. Frequent mutations of the rat β-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone
8. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse
9. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
10. Chemoprevention of spontaneous intestinal adenomas in the Apc min mouse model by the nonsteroidal anti-inflammatory drug piroxicam
11. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo
12. Pathology of tumors in laboratory animals
13. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats
14. No involvement of Ki-ras or p53 gene mutations in colitis-associated rat colon tumors induced by 1-hydroxyanthraquinone and methyl azoxymethanol acetate
15. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
16. N-Ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: Age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts
17. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice
18. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse
19. Activation of the nuclear receptor PPARγ enhances colon polyp formation
20. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APC Min/+ mice
21. Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice
22. Sucrose enhancement of the early steps of colon carcinogenesis in mice
23. Aberrant crypts: Potential preneoplastic lesions in the murine colon
24. Frequent mutations of the β-catenin gene in mouse colon tumors induced by azoxymethane
25. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
26. A β-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of β-catenin germline mutations in FAP patients
27. Germ-line mutations the APC gene in 53 familial adenomatous polyposis patients
28. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis
29. Molecular diagnosis of familial adenomatous polyposis
30. Inactivation of both APC alleles in early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP)
31. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP)
32. The APC gene product in normal and tumor cells
33. Loss of Apc+ in intestinal adenomas from Min mice
34. AOM-induced mouse colon tumors do not express full-length APC protein
35. Inactivation of both APC alleles in human and mouse tumors
36. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the min/+ mouse colon
37. Genetic alterations during colorectal-tumor development
38. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence